Inhibition of recombinant N-terminal GST-tagged human DLK (9 to 111 residues) expressed in Sf21 cells assessed as reduction in substrate phosphorylation using MKK4 and ATP as substrate incubated for 1.5 hrs by HTRF analysis
Inhibition of recombinant N-terminal GST-tagged human LZK (9 to 114 residues) expressed in Sf21 cells assessed as reduction in substrate phosphorylation using MKK4 and ATP as substrate incubated for 1.5 hrs by HTRF analysis
Inhibition of human DLK expressed in HEK cells assessed as reduction in phospho-c-Jun level preincubated for 45 mins followed by doxycycline stimulation and measured after 24 hrs by MSD ELISA
Inhibition of human LZK expressed in HEK cells assessed as reduction in phospho-c-Jun level preincubated for 45 mins followed by doxycycline stimulation and measured after 24 hrs by MSD ELISA
Neuroprotective activity against CD-1 mouse DRG neurons transfected with mCherry assessed as reduction in axonal degeneration at 1 uM incubated for 20 hrs in NGF deprived medium by fluorescence microscopic analysis
Neuroprotective activity against CD-1 mouse DRG neurons transfected with mCherry assessed as reduction in caspase activation at 1 uM incubated for 20 hrs in NGF deprived medium by fluorescence microscopic analysis
Neuroprotective activity against CD-1 mouse DRG neurons transfected with mCherry assessed as reduction in axonal degeneration at 0.1 to 0.3 uM incubated for 20 hrs in NGF deprived medium by fluorescence microscopic analysis
Neuroprotective activity against CD-1 mouse DRG neurons transfected with mCherry assessed as reduction in caspase activation at 0.1 to 0.3 uM incubated for 20 hrs in NGF deprived medium by fluorescence microscopic analysis